• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form EFFECT filed by Calithera Biosciences Inc.

    3/20/23 12:15:06 AM ET
    $CALA
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $CALA alert in real time by email
    Notice of Effectiveness
    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
    Notice of Effectiveness
    Effectiveness Date: March 17, 2023
    Accession Number: 0001193125-23-070124
    Submission Type: POS AM
    CIK: 0001496671
    Company Name: Calithera Biosciences, Inc.
    File Number: 333-243731
    Get the next $CALA alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $CALA

    DatePrice TargetRatingAnalyst
    1/31/2022$4.00Buy
    Ladenburg Thalmann
    1/20/2022$1.00 → $3.00Market Perform → Outperform
    SVB Leerink
    11/8/2021Buy → Neutral
    HC Wainwright & Co.
    11/5/2021Outperform → Market Perform
    William Blair
    More analyst ratings